Skip to main content
Clinical Trials/CTRI/2025/09/094647
CTRI/2025/09/094647
Not yet recruiting
Not Applicable

Effectiveness of inspiratory muscle trainer on pulmonary function and functional capacities in phase 1 cardiac rehabilitation

Dr Nigam Subhash Nagdeve1 site in 1 country130 target enrollmentStarted: September 11, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Dr Nigam Subhash Nagdeve
Enrollment
130
Locations
1
Primary Endpoint
Inspiratory muscle trainer

Overview

Brief Summary

Cardiac rehabilitation is defined by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) as the delivery of all-inclusive, long-term services that include medical evaluation, prescription exercise, modification of cardiac risk factors, education, counseling, and behavioral interventions. The inspiratory muscle trainer device benefits includes improved pulmonary function, respiratory muscle strength and endurance, functional capacity, physical activity, and health-related quality of life used  patients.Efficacy of inspiratory muscle trainer during Phase 1 of cardiac rehabilitation has not been well studied.

This randomized clinical trial aimed to evaluate and  the effects of Inspiratory muscle trainer  who underwent  Phase 1 of their cardiac rehabilitation.

Procedure : Participants will be selected and screened based on inclusion and exclusion criteria. Details about the study and intervention will be explained to the participants and an informed written consent form will be obtained. Patient’s will be Randomly divided through block randomisation method into Group A (control  ) and Group B ( IMT). Outcomes will be assessed on pod 1 and treatment will be given from POD 2 to POD 6 to Patients who underwent through cardiac rehabilitation  On Postoperative day 6 outcomes will be reassessed. Data will be collected from both groups and analyzed for significant differences in pulmonary function and airway clearance improvements. Statistical tests will be used to compare the efficacy of inspiratory muscle trainer  devices in enhancing respiratory outcomes in phase 1 cardiac rehab patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1 A minimum 40% ejection fraction 2 Heart valve surgery, left or right 3 Minimum age of eighteen years 4 NYHA I–III stable heart failure CABG 5 Coronary artery percutaneous intervention.

Exclusion Criteria

  • BP higher than 200mg in systolic and 110 in diastolic ,ischemic ECG alteration, uncontrolled tachycardia instable angina, AV block of third degree.

Outcomes

Primary Outcomes

Inspiratory muscle trainer

Time Frame: Postoperative day 1 | Postoperative day 6

Secondary Outcomes

  • 6 Minute walk test(Postoperative day 1)

Investigators

Sponsor
Dr Nigam Subhash Nagdeve
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Nigam Subhash Nagdeve

Datta Meghe College Of Physiotherapy ,Nagpur

Study Sites (1)

Loading locations...

Similar Trials